Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

463

HTML

3690

Figures (1-2)

182

Tables (1-5)

176

Sum=4511

Dec 15, 2004 (publication date) through Jun 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 15, 2004; 10(24): 3634-3638
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3634

Table 3 Efficacy of 46 evaluable patients treated with H101 and chemotherapy

¹SCCHN, squamous cell carcinoma of head and neck.

Citation: Lu W, Zheng S, Li XF, Huang JJ, Zheng X, Li Z. Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial. World J Gastroenterol 2004; 10(24): 3634-3638
URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3634.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3634